Abstract

The envelope of hepatitis B virus (HBV), which is required for the entry to hepatocytes, consists of a lipid bilayer derived from hepatocyte and HBV envelope proteins, large/middle/small hepatitis B surface antigen (L/M/SHBs). The mechanisms and host factors for the envelope formation in the hepatocytes are being revealed. HBV-infected hepatocytes release a large amount of subviral particles (SVPs) containing L/M/SHBs that facilitate escape from the immune system. Recently, novel drugs inhibiting the functions of the viral envelope and those inhibiting the release of SVPs have been reported. LHBs that accumulate in ER is considered to promote carcinogenesis and, especially, deletion mutants in the preS1/S2 domain have been reported to be associated with the development of hepatocellular carcinoma (HCC). In this review, we summarize recent reports on the findings regarding the biological characteristics of HBV envelope proteins, their involvement in HCC development and new agents targeting the envelope.

Highlights

  • Involvement in Carcinogenesis.Hepatitis B virus (HBV) infects 292 million people chronically in the world despite the availability of an effective vaccine [1], and they are at risk of liver cirrhosis and hepatocellular carcinoma (HCC) [2]

  • Antiviral therapies such as nucleos(t)ide analogues (NAs) and interferon have been developed, complete eradication of hepatitis B virus (HBV) is still difficult because covalently closed circular DNA, which is a highly stable and active episomal genome, is formed in the nucleus of HBV-infected hepatocytes [3]

  • We summarize marize the biological characteristics of HBV envelope and subviral particles (SVPs) and the roles of envelope the biological characteristics of HBV envelope and SVPs and the roles of envelope proteins proteins in the hepatocarcinogenesis

Read more

Summary

Introduction

Hepatitis B virus (HBV) infects 292 million people chronically in the world despite the availability of an effective vaccine [1], and they are at risk of liver cirrhosis and hepatocellular carcinoma (HCC) [2]. The. HBV envelope, which is considered to be essential for the infection [12], is composed of a cellular lipid bilayer and three HBV surface proteins: large/middle/small hepatitis B surface proteins (LHBs/MHBs/SHBs). Viruses 2021, 13, 1124 cellular lipid bilayer and three HBV surface proteins: large/middle/small hepatitis B surface proteins (LHBs/MHBs/SHBs).

Biological Characteristics of HBV Envelope
Model depicting thethe steps of HBV
Subviral Particles of HBV
HBV Envelope Proteins as Clinical Diagnostic Tools
Genetic Variations of HBV Envelope
HBV Envelope Protein as a Cause of HCC
Inhibition of HBV Entry
Inhibition of HBV Envelope Protein Release
Inhibition of HBV Enveloping of the HBV Nucleocapsids
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call